Fairvalue-Calculator Fairvalue-Calculator
EN DE

Les Hôtels Baverez S.A (ALLHB) Fair Value & Analysis

Consumer Cyclical · FR · Market cap €178M

Price€76.00
Fair Value€15.72
Upside-79.3%
Quality95/100
Evidence: High Range €14.56 – €20.44

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Les Hôtels Baverez S.A (ALLHB) currently trades at €76.00, while our model-based Fair Value estimate is €15.72 — implying the stock looks roughly 79.3% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Les Hôtels Baverez S.A. owns and operates 5-star hotels in France. It operates three hotels, including Hotel Regina; Hotel Raphael; and Majestic Hôtel-Spa. The company's hotels include restaurants and wellness areas. Les Hôtels Baverez S.A. was incorporated in 1957 and is headquartered in Paris, France.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Les Hôtels Baverez S.A (ALLHB) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €15.72 versus a price of €76.00 — about −79% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALLHB?
Our 21-model fair value for Les Hôtels Baverez S.A is €15.72 (as of Jun 24, 2026), built from audited fundamentals. The current price is €76.00.
What is the quality score of ALLHB?
Les Hôtels Baverez S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.